» Articles » PMID: 12901699

Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients

Overview
Specialties Neurology
Pathology
Date 2003 Aug 7
PMID 12901699
Citations 245
Authors
Affiliations
Soon will be listed here.
Abstract

The extent and pattern of demyelination in the cerebral cortex was determined in 78 tissue blocks from the brains of 20 multiple sclerosis (MS) patients and 28 tissue blocks from 7 patients without neurological disease. Tissue blocks from 4 predetermined areas (cingulate gyrus, frontal, parietal, and temporal lobe) were studied, irrespective of macroscopically evident MS plaques. All tissue blocks contained cerebral cortex and periventricular and/or subcortical white matter. One hundred and nine demyelinating lesions were detected in the cerebral cortex, of which 92 (84.4%) were purely intracortical and 17 (15.6%) were lesions extending through both white and gray matter areas. In 5 of the 20 MS brains, subpial demyelination was extensive in the 4 widely spaced cortical areas studied, thus considered to represent a general cortical subpial demyelination. The percentage of demyelinated area was significantly higher in the cerebral cortex (mean 26.5%, median 14.1%) than in white matter (mean 6.5%, median 0%) (p = 0.001). Both gray and white matter demyelination was more prominent in the cingulate gyrus than in the other areas examined (p < 0.05). These results indicate that the cerebral cortex is likely to be a predilection site for MS lesions and identify general cortical subpial demyelination as a distinct pattern occurring in a significant subpopulation of MS patients.

Citing Articles

Scaling up spatial transcriptomics for large-sized tissues: uncovering cellular-level tissue architecture beyond conventional platforms with iSCALE.

Schroeder A, Loth M, Luo C, Yao S, Yan H, Zhang D bioRxiv. 2025; .

PMID: 40060412 PMC: 11888418. DOI: 10.1101/2025.02.25.640190.


Immunoexcitoxicity as the possible major pathophysiology behind multiple sclerosis and other autoimmune disorders.

Blaylock R Surg Neurol Int. 2025; 16:26.

PMID: 39926461 PMC: 11799683. DOI: 10.25259/SNI_1114_2024.


A New Perspective on Mechanisms of Neurodegeneration in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: the Early and Critical Role of Platelets in Neuro/Axonal Loss.

Orian J J Neuroimmune Pharmacol. 2025; 20(1):14.

PMID: 39904925 PMC: 11794395. DOI: 10.1007/s11481-025-10182-w.


Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study.

Ziccardi S, Crescenzo F, Guandalini M, Caliskan G, Martinelli L, Tamanti A Brain Commun. 2024; 6(6):fcae355.

PMID: 39494361 PMC: 11528517. DOI: 10.1093/braincomms/fcae355.


Spatial transcriptomics of meningeal inflammation reveals inflammatory gene signatures in adjacent brain parenchyma.

Gadani S, Singh S, Kim S, Hu J, Smith M, Calabresi P Elife. 2024; 12.

PMID: 39475792 PMC: 11524578. DOI: 10.7554/eLife.88414.